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ARTICLE

OPEN
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The role and biological signiﬁcance of gene-environment interactions in human traits and diseases remain poorly understood. To
address these questions, the CHARGE Gene-Lifestyle Interactions Working Group conducted series of genome-wide interaction
studies (GWIS) involving up to 610,475 individuals across four ancestries for three lipids and four blood pressure traits, while
accounting for interaction effects with drinking and smoking exposures. Here we used GWIS summary statistics from these studies
to decipher potential differences in genetic associations and G×E interactions across phenotype-exposure-ancestry combinations,
and to derive insights on the potential mechanistic underlying G×E through in-silico functional analyses. Our analyses show ﬁrst
that interaction effects likely contribute to the commonly reported ancestry-speciﬁc genetic effect in complex traits, and second,
that some phenotype-exposures pairs are more likely to beneﬁt from a greater detection power when accounting for interactions. It
also highlighted modest correlation between marginal and interaction effects, providing material for future methodological
development and biological discussions. We also estimated contributions to phenotypic variance, including in particular the
genetic heritability conditional on the exposure, and heritability partitioned across a range of functional annotations and cell types.
In these analyses, we found multiple instances of potential heterogeneity of functional partitions between exposed and unexposed
individuals, providing new evidence for likely exposure-speciﬁc genetic pathways. Finally, along this work, we identiﬁed potential
biases in methods used to jointly meta-analyze genetic and interaction effects. We performed simulations to characterize these
limitations and to provide the community with guidelines for future G×E studies.
European Journal of Human Genetics (2022) 30:730–739; https://doi.org/10.1038/s41431-022-01045-6

INTRODUCTION
The precise role of gene-environment interactions (G×E) in
complex human traits and disease traits remains unclear.
Although genome-wide G×E studies have been conducted for
many phenotypes, the number of identiﬁed G×E is very small
relative to the large number of genetic variants identiﬁed in
traditional genome-wide association studies (GWAS). A number of
issues related to the identiﬁcation of G×E have been well
described in the literature [1–3], including in particular very low
power [4]. As a result, the required sample size needed to detect
G×E is substantially larger than for marginal genetic effect (i.e.,
genetic effect estimated from a model not accounting for G×E).
Moreover, few studies have explored potential differences in G×E

across ancestry, assessed the contribution of G×E to the variance
of human phenotypes, or explored enrichment of G×E for speciﬁc
functional mechanisms.
The Gene-Lifestyle Interactions Working Group [5] within the
Cohorts for Heart and Aging Research in Genetic Epidemiology
(CHARGE) is an international initiative that has the potential to
address some of these challenges. It is a large-scale, multi-ancestry
consortium that aims at systematically evaluating genome-wide
gene-lifestyle interactions on cardiovascular disease-related traits
using genotypic data from up to 610,475 individuals. The
consortium published a series of genome-wide single nucleotide
polymorphism (SNP) by smoking and drinking interaction screenings focusing on four blood pressure phenotypes: diastolic blood
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pressure (DBP), systolic blood pressure (SBP), pulse pressure (PP),
mean arterial pressure (MAP), and three lipid levels: triglycerides
(TG), high-density lipoprotein cholesterol (HDL), and low-density
lipoprotein cholesterol (LDL). For each pair of a phenotype and an
exposure, a genome-wide interaction studies (GWIS) using the 1
degree of freedom (df) test for G×E interaction and the 2df joint
test of main genetic effect (i.e. the estimate of genetic effect from
the interaction model) and G×E interaction effects [6] has been
conducted. The results from these analyses have been published
in ﬁve papers: SNP-by-alcohol interaction [7] and SNP-by-smoking
interaction [8, 9] on blood pressure, and SNP-by-alcohol interaction [10] and SNP-by-smoking interaction on lipids [11].
Here we ﬁrst synthesize the GWIS results for all phenotypeexposure combinations. We highlight the importance of our largescale initiative, providing evidence that interacting variants might
differ by genetic ancestry, and show that accounting for G×E can
help to discover new loci, especially for certain phenotypeexposure pairs. We then performed a series of analyses comparing
interaction effects against marginal genetic effects derived from
both our studies and from previous GWAS. Contrary to a
commonly assumed hypothesis [12], we found only modest
correlation between interaction effect and marginal effect, highlighting additional challenges for future G×E interactions studies.
Estimated variance explained by main and interaction effect for
the outcomes under study also showed that in general,
interactions explain a very small amount of phenotypic variance
on top of the marginal genetic effect for these traits. However,
these limitations were balanced by stratiﬁed heritability analyses.
Partitioning the genetic variance in exposed and unexposed
individuals separately, using both functional and cell-type
annotations, we observed differential enrichment patterns
between the two groups in multiple instances. This suggests
G×E might still play an important role in these phenotypes, with
some exposures potentially triggering new molecular mechanisms
or reducing the contribution of pathways involved in unexposed
individuals.
METHODS
Data and processing

and a maximum physical distance from the lead SNP (i.e., the most
associated variant) of ±500 kb. The LD was derived using 1000 Genomes
Project [14] individuals as a reference panel while accounting for ancestry.
We used the EUR, AFR, combined EAS-SAS, and AMR samples as proxies for
the individuals from European ancestry (EA), African ancestry (AA), Asian
ancestry (ASA), and Hispanic ancestry (HA), respectively. For the transancestry analyses, we built our reference panel by merging all those
reference populations. Associated loci are genetic regions of 1 Mb or more
harboring at least one genome-wide associated SNPs. To deﬁne associated
loci, we ﬁrst derived region 500 kb upstream and downstream of each and
every independent signal (as deﬁned above). All overlapping regions were
then merged to form the loci. Further details are provided in the
Supplementary Note

Interaction effect conditional on marginal effect
We assessed potential enrichment for interactions effects for SNPs displaying
marginal genetic association. To increase independence between our
interaction effect GWIS and the marginal GWAS, we used summary statistics
from previous studies on blood pressure traits [15–17] and lipid traits [18–21].
However, note that there might be a small overlap of samples between some
of these previously published marginal GWAS and the 1df and 2df GWIS from
the CHARGE consortium. For this analysis, we considered only individuals of EA,
in order to maximize the sample size while limiting potential issues due to
genetic heterogeneity, where the top variants might differ across populations.
In practice we used the 1df interaction test from the combined analysis
derived in European sample in CHARGE, and for external studies, we used only
the GWAS conducted in European populations. Moreover, to avoid enrichment
driven by a single locus, we performed a clumping of the previously published
GWAS of marginal genetic effect with PLINK [13], so that all lead SNPs
considered are independent from each other. We ﬁrst derived the proportion
of interaction effect nominally signiﬁcant at type I error rate (alpha) threshold
of 0.05 among bins of SNPs grouped based on their marginal association (i.e.,
we derive the proportion of SNPs with interaction p value below 0.05 and
p value for marginal effect in bins [1, 0.1], [0.1, 0.01], [0.01, 0.001], etc). Note that
the aforementioned clumping of SNPs avoids any biased enrichment due to
pairwise SNP correlation. For the last bin, including only SNPs previously
identiﬁed at genome-wide signiﬁcance level (5 × 10−8) in marginal effect
GWAS, we also performed three complementary association tests [4] to assess
interaction effects that would have been missed by single SNP G×E interaction:
an omnibus test, an unweighted genetic risk score (uGRS) test, and a weighted
genetic risk score (wGRS) (see Supplementary Note).

Variance explained and heritability

We considered four blood pressure phenotypes (DBP, SBP, PP, MAP), and
three lipids levels (TG, HDL, LDL). Two binary smoking exposures, current
smoking and ever smoking, were considered and measured similarly across
all smoking GWIS. The current smoking variable was coded as 1 if the
subject smoked regularly in past year and as 0 otherwise. Ever smoking
status was coded as 1 if the subject smoked at least 100 cigarettes during
his/her lifetime and 0 otherwise. For alcohol consumption, two binary
variables were considered, referred further as current drinking and drinking
habit. All studies conducted a two-stage approach. In stage 1 (referred to
as Discovery), a standard GWIS was performed using up to 18 million
genetic variants. In stage 2 (referred to as Replication), only a subset of
variants with a p value for either 1df or the 2df test below a certain
threshold (P < 10−6 or P < 10−5) at stage 1 were further considered. For
each outcome exposure, we had access to complete meta-analysis
summary statistics of both the discovery and the replication stages for
four different ancestries (European, African, Asian, and Hispanic) after
quality control ﬁltering. To ensure a fair comparison, we re-processed all
results for each outcome-exposure-ancestry combination using the same
pipeline. More details are provided on the data and pre-processing are
available in the supplementary notes and in the corresponding publications [7–11].

For each ancestry and each phenotype-exposure combination, we derived
from the combined (stage 1 and stage 2) results the fraction of phenotypic
variance explained by top SNPs was decomposed into main effects,
interaction effects and those effects jointly using the R package VarExp
[22]. The signiﬁcance of the variance explained by interaction effects was
derived using an approximation of the joint test of all interaction effects.
For EA samples, we further assessed potential differences in heritability
across exposure-speciﬁc strata using stage 1 genome-wide association
results using the LDSC approach [23]. We used the pre-computed LDscore
relative to EA samples provided with the software. When unavailable from
the original studies, stratiﬁed results were derived from the interaction
model using J2S [24]. For each exposure stratum, genetic heritability was
further partitioned by both cell-type-speciﬁc and general annotations [25]
using two distinct sets of annotations: baseline and GenoSkyline+. The
signiﬁcance of the annotation enrichment was assessed using a Bonferroni
corrected signiﬁcance threshold of P < 0.000277. Tissue-speciﬁc heritability
was also derived following Finucane et al. [26]. Except when speciﬁed
otherwise, enrichment analyses compared median enrichment between
exposure strata. We avoided comparison of signiﬁcance level here, which
would be biased by differences in sample size. Additional details of these
analyses are provided in the Supplementary Note.

Identiﬁcation of independent signals and associated loci

RESULTS
Overview
We investigated results from 28 GWIS on three lipid and four
blood pressure phenotypes, each examining G×E interaction with
two smoking and two alcohol exposures (Table 1). All outcomeexposure pairs were analyzed using a two-stage approach
involving up to 610,475 individuals. In stage 1, a GWIS was

We deﬁned two levels of association when reporting genome-wide
signiﬁcant variants in the combined meta-analyses (P < 5 × 10−8): independent signal (lead SNPs after clumping) and associated locus (genetic
regions of 1 Mb with at least one independent signal). Independent signals
represent independent SNPs associated at genome-wide signiﬁcance level.
Independent signals were deﬁned using the clumping framework from the
PLINK software [13], using a linkage disequilibrium (LD) threshold of 0.2
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Table 1.

Summary of trans-ancestry GWIS results for 2df joint and 1df interaction tests.

Outcome
Lipids

Exposure
HDL

LDL

TG

Blood pressure

SBP

DBP

MAP

PP

# variants

Sample sizea
(disc)

Sample sizea
(rep)

# Loci (signals)b
2df

# loci (signals)b
1df

Current drinking

7,505,310

127,252

231,043

111 (584)

0 (0)

Drinking habits

6,848,811

118,899

217,468

109 (528)

0 (0)

Current smoking

6,306,314

133,508

253,467

69 (335)

0 (0)

Ever smoking

7,269,995

133,816

251,711

74 (370)

0 (0)

Current drinking

7,448,913

118,654

171,142

92 (492)

0 (0)

Drinking habits

6,834,699

111,093

155,280

78 (446)

0 (0)

Current smoking

6,261,354

125,629

188,109

53 (251)

0 (0)

Ever smoking

7,251,615

125,638

186,230

45 (163)

0 (0)

Current drinking

7,410,534

104,716

221,722

71 (413)

0 (0)

Drinking habits

6,839,760

103,214

210,623

72 (365)

0 (0)

Current smoking

7,122,377

111,900

241,140

52 (220)

0 (0)

Ever smoking

8,438,564

111,909

238,972

49 (226)

0 (0)

Current drinking

7,489,960

121,948

426,121

55 (106)

0 (0)

Drinking habits

10,639,279

62,479

114,058

29 (47)

0 (0)

Current smoking

6,849,695

127,730

474,475

66 (139)

0 (0)

Ever smoking

7,928,860

127,733

458,034

68 (137)

0 (0)

Current drinking

7,490,269

121,947

426,177

57 (101)

0 (0)

Drinking habits

10,639,829

62,479

114,111

31 (42)

0 (0)

Current Smoking

6,784,799

127,730

474,531

70 (138)

0 (0)

Ever smoking

7,930,829

127,730

458,089

66 (136)

0 (0)

Current drinking

7,489,903

121,947

426,112

48 (71)

0 (0)

Drinking habits

10,639,231

62,479

113,287

32 (46)

0 (0)

Current smoking

6,848,964

127,730

474,465

69 (144)

1 (1)

Ever smoking

7,932,503

127,730

458,024

67 (137)

0 (0)

Current drinking

7,489,921

121,947

420,767

39 (67)

0 (0)

Drinking habits

10,639,279

62,479

114,111

18 (27)

0 (0)

Current smoking

7,934,402

127,730

473,514

54 (92)

0 (0)

Ever smoking

7,934,402

127,730

457,073

54 (90)

0 (0)

HDL high-density lipoprotein, LDL low-density lipoprotein, TG triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial
pressure, PP pulse pressure, 1df 1 degree of freedom interaction test, 2df 2 degrees of freedom joint test, disc Discovery stage, rep replication stage.
a
Maximum sample size across all variants analyzed.
b
Plain text number corresponds to the count of associated loci (region of 1 Mb or more harboring at least one GWAS hit), while the number of independent
association signals (associated SNPs remaining after clumping) is provided in parenthesis.

performed in up to 29 cohorts with a total of up to 149,684
individuals from four ancestries: EA, AA, ASA, and HA. In stage 2,
involving up to 71 additional cohorts including 460,791 individuals, also from multiple ancestries, studies focused on the
replication of a subset of variants from stage 1. The total sample
size (discovery and replication) varied substantially across the trait
analyzed, with an average of 311 K for lipids and 457 K for blood
pressure traits. Moreover, our analyses explored not only the 28
primary trans-ancestry GWIS, but also the 112 corresponding
ancestry-speciﬁc GWIS. To ensure a fair comparison across all
analyses, we re-processed all GWIS summary results using the
same pipeline. Stage 1 quantile-quantile (QQ) plots for both the
1df and the 2df test are presented in Fig. S1, and frequency of the
exposure are presented in Fig. S2 and Table S1. Finally, note that
the primary association results from the original studies and our
analyses are highly concordant, but minor differences might exist
because of slight differences in the analysis pipeline.
Identifying single SNP G×E is challenging but accounting for
G×E still boost power
Despite the reasonably large sample size available in our studies,
there was only one signiﬁcant interaction signal with the 1df

interaction test across the 28 trans-ancestry GWIS when combining discovery and replication (rs1626071 on chr10 near gene
LINC01517, interaction with current smoking on MAP, P1df = 3.19 ×
10−8). For the ancestry-speciﬁc meta-analysis, the 1df interaction
test identiﬁed 8 loci reaching genome-wide signiﬁcance, all
observed in the African ancestry population (Table S2). They
involved the smoking exposure only, and are associated with both
lipids and blood pressure traits. Four of those loci were also
detected at genome-wide signiﬁcance with the 2df test in the
African ancestry population, while the remaining four associations
achieve suggestive signiﬁcance with that test (P2df between 1.9 ×
10−6 and 6.3 × 10−8).
In sharp contrast with the 1df interaction test, the 2df joint test
identiﬁed a large number of variants in both the trans-ancestry
(Table 1) and ancestry-speciﬁc (Tables S3 and S4) meta-analyses.
Altogether, the 2df trans-ancestry analyses identiﬁed a total of
1698 loci-phenotype associations (see “Methods” for the deﬁnition
of loci), when summing results over all phenotypes and all
exposures. Among those, a total of 54% of the loci (N = 926)
harbored a single independent association signal, while others
display multiple independent signals (Fig. S3). Many loci overlapped across the exposures tested. For example, there were 108
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Fig. 1 Loci identiﬁed by the trans-ancestry 2df joint test across the four exposures. We assessed the relative performance of the transancestry joint 2df test across the four exposures. a Overlapping loci for the 2df test across the four exposures. We further decomposed these
results by exposure, for current drinking (b), drinking habit (c), current smoking (d), ever smoking (e). The corresponding radar plots show the
proportion (from 0% to 100%) of the total number of loci identiﬁed for that phenotype.

and 103 loci identiﬁed for HDL when including interaction
between current drinking and drinking habits, respectively.
However, 92 of those loci were identiﬁed in both analyses.
Merging all overlapping loci unraveled by different exposure
scans, the 2df scans found a total of 112, 98, 77 loci for HDL, LDL,
TG, and 74, 75, 75, and 59 loci for SBP, DBP, MAP, and PP
respectively. On average, 13% of the loci were identiﬁed by a
single exposure scan, while 41% were identiﬁed by all four
exposure association studies for each phenotype (Fig. 1a).
We compared the trans-ancestry 2df results against 599 signiﬁcant
marginal genetic effect association on the two primary blood
pressure traits (DBP and SBP) [15–17] and the three lipid traits
[20, 27] retrieved from previous studies (Tables S5, S6, Fig. S4, and
“Methods”). Among those, 294 were also found genome-wide
signiﬁcant in our studies, and 305 associations did not reach this
signiﬁcance threshold. Conversely, the trans-ancestry 2df screenings
identiﬁed 119 novel loci-outcome associations. Most of the new
association results for lipids were identiﬁed when accounting for
interaction with drinking exposures, while the majority of new blood
pressure associations were identiﬁed when accounting for interaction with smoking exposures (Table 2). Part of these observed
differences might be explained by heterogeneity in sample size (e.g.
N was substantially smaller for BP and drinking habits as compared
to BP and other exposure). However, sample size for all other
phenotype-exposure pairs were fairly very similar (<14%) and
unlikely to explain difference in number of replicated signal (e.g. for
HDL, Ndrinking habits = 379 K, Ncurrent smoking = 384 K, and number of
replicated signals equals 17 and 11, respectively). We also derived
the association signal from the combined stage 1 and 2 SNPs that
would have been obtained using a standard marginal genetic effect
in the CHARGE data, while adjusting for the effect of the exposure,
but not modeling the interaction. The marginal model replicated
only at a similar proportion of signal, 48% (N = 289) as compared to
49% (N = 294) of the 599 previously reported associations. Among
the 119 new associations detected by the 2df test, 29% (N = 35) did
not passed the genome-wide signiﬁcance level with the marginal
model, highlighting the importance of accounting for G×E to detect
new associated variants.

European Journal of Human Genetics (2022) 30:730 – 739

G×E effects might vary by exposure and ancestry
When stratifying the 2df joint test results by exposure, accounting
for interaction with drinking tended to identify more lipids
associations, while accounting for interaction with smoking
identiﬁed more associations for blood pressure phenotypes
(Fig. 1b–e). Looking at cross-phenotypes results, GWIS accounting
for current drinking and drinking habits captured 81% and 61% of
all loci, respectively, and current smoking and ever smoking scans
identiﬁed 75% and 72% of all loci respectively. Note that the lower
number of signals for drinking habits is likely partly explained by
the smaller sample size used for that exposure (307 K on average
versus 440 K for the other exposures), especially for the BP GWIS
that used a different deﬁnition for drinking habits (see “Methods”).
To understand the differences observed across other exposures,
we used the HDL results as a case study. First, we noticed that the
chi-squared from the 2df joint test from overlapping loci across
the four exposure scans were highly correlated (Fig. S5a). This is
expected, as most studies have approximately the same sample
size at discovery and replication stages, and contribution of the
interaction effect is assumed to be limited. Nevertheless, we
noticed a larger mean interaction effect chi-square at those same
loci for the drinking exposures (χ 2 = 1.57, P = 8.7 × 10−5 and 1.58,
P = 1.2 × 10−4) as compared to the smoking exposures (χ 2 = 1.07,
P = 0.32 and 1.09, P = 0.28), suggesting a potential contribution of
SNP-by-drinking interaction effect (Fig. S5b).
Over the two stages, 63% of the individuals (N = 380,612) were of
European, 27% (N = 162,370) of Asian, 6% (N = 34,901) of African
and 4% (N = 22,334) of HAs. For the 2df joint test, the total number
of signiﬁcant associations per ancestry was, as expected, signiﬁcantly
positively correlated to the available sample size (r2 = 0.42, 95% CI =
[0.25, 0.57], P = 1.1 × 10−5) (Table S3). When merging results from all
phenotype-exposure pairs, there were 1,285, 383, 135, and 148
phenotype-variants associations identiﬁed after clumping by this
approach in EA, ASA, AA, and HA ancestries, respectively. The vast
majority of the loci found in the ASA (95%) and HA (99%) ancestries
were also identiﬁed in the larger EA studies (Fig. 2a). Conversely, 32%
(43 out of 135) of the associations identiﬁed in AA were exclusively
identiﬁed in this ancestry and mostly involved variants not present in
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Table 2.

Association signal overlap between the 2df joint test (accounting for interactions) and previous GWAS of marginal genetic effect.

Phenotype

Overall
External GWAS only

CHARGE only, per exposure
Current drinking

Drinking habits

Current smoking

Ever smoking

HDL

70

83

21

18

17

11

11

LDL

60

63

30

25

17

6

6

TG

91

57

15

9

11

6

5

SBP

33

37

35

21

6

27

28

DBP
All

Both

CHARGE only

47

46

26

16

4

22

17

301

286

127

89

55

72

67

HDL high-density lipoprotein, LDL low-density lipoprotein, TG triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, 1df 1 degree of freedom
interaction test, 2df 2 degrees of freedom joint test, disc discovery stage, rep replication stage.

Fig. 2 Overlapping associations for the 2df test across ancestries. We derived the overlap in association signal for the joint 2df test of main
and interaction effects across the four ancestries: Asian (ASA), African American (AA), European (EA), and Hispanic (HA). a A Venn diagram
focusing only on loci found at genome-wide signiﬁcance level after the meta-analysis of stages 1 and 2. In b we extracted genome-wide
signiﬁcant SNPs per ancestry (i.e., reference population) after the meta-analysis of stages 1 and 2, and extracted the p value for those SNPs in
other populations (i.e., the matching populations) from stage 1. The barplot shows for each reference population, the proportion of SNPs in
the matching population that achieve a p value below 0.05. For each comparison, we also derived the expected number of hits based on the
effect size estimate in the reference population and the sample size in the matching population.

all ancestries except in AA (in non-AA ancestry populations, 60% of
those variants were ﬁltered out at stage 1 because of low frequency).
The trans-ancestry analysis identiﬁed 1276 (94%) of all ancestryspeciﬁc associations, while uncovering an additional 148 associations.
All associations missed in the trans-ancestry analyses were found in a
single ancestry from ASA (N = 6), AA (N = 36), EA (N = 41), and HA
(N = 1). To account for sample size differences and assess whether
top variants were consistent across ancestries, we extracted the top
variants for each ancestry-speciﬁc association and checked for
nominal signiﬁcance (P < 0.05) in other ancestries screenings from
stage 1. Figure 2b shows that the overlap across all phenotypes and
per phenotype is modest. These results, along the aforementioned
1df signiﬁcant signals unique to the AA samples, suggest the
presence of ancestry-speciﬁc variants and G×E s, and in AA in
particular.
Correlation between marginal genetic and interaction effect
are negligible
To understand further the contribution of G×E to signiﬁcant 2df
results, we derived for each phenotype-exposure-ancestry combination (N = 12,302, see Table 1 and Table S3) the number of SNPs
inducing an enhanced genetic effect in exposed individuals (when
main genetic effect and interaction effect have the same
direction) and those inducing a reduced genetic effect (when
main and interaction have opposite signs). In practice, we used
the marginal genetic effect as a proxy for the main effect, as the
former parameter has better properties for such an analysis (i.e.,

the marginal effect is expected to be independent of the
interaction effect under the null [12], while the main effect does
not [4]). Note that this subtlety has almost no impact on the
results as the main and marginal are highly correlated (ρ = 0.99)
among the signiﬁcant 2df variants. Overall, the direction of
marginal and interaction effects estimated using the 1df test
tended to be randomly distributed among those SNPs, although
we observed a slight enrichment, with 13 out of 91 trios showing
disequilibrium for either concordant or discordant effects (one
sided binomial test P = 6 × 10−4, Fig. S6). Four of them, all in the
trans-ancestry analyses, displayed discordant marginal and interaction effect that remained signiﬁcant after correcting for multiple
testing (P < 5.5 × 10−4): LDL showed larger genetic effects in both
current (P = 4.3 × 10−4) and ever smokers (P = 3.7 × 10−4), DBP
showed larger genetic effects in current drinkers (P = 1.6 × 10−4),
and SBP showed smaller genetic effects among ever smokers (P =
9.9 × 10−5). Among sets of variants displaying interaction effects
discordant with marginal genetic effects, we also searched for
those inducing an opposite effect between exposed and
unexposed individuals. Although the 2df joint test is supposed
to outperform substantially the marginal test in this scenario [4],
there were only 66 such associations (0.6% of all associations),
suggesting this pattern is quite rare in these data.
We next assessed potential enrichment for interaction effects
across variants previously identiﬁed in marginal effect GWAS
[15–17, 20, 27] (Tables S5 and S6) and available in the transancestry stage 1 analyses. Among those variants, the smallest single
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Fig. 3 Potential power for 2-step approach. We plotted for each environmental exposure, current drinking (a), drinking habits (b), current
smoking (c) and ever smoking (d), the proportion of independent SNPs displaying an interaction p value (Pint) below 0.05 in CHARGE across
bins of variants selected from an independent marginal effect GWAS. Those bins were deﬁned as sets of independent variants with p value for
marginal genetic effect (Pmarg) lower than a given threshold (x axis). Each of the ﬁve phenotypes are represented by a plain color line. All
analyses used stage 1 1df interaction results from European ancestry individuals. Under the null hypothesis of no correlation, the proportion
follows a binomial distribution with parameter 0.05 (the black dashed line), independent of the threshold for Pmarg. Gray areas indicate the
Wilson score conﬁdence interval for an alpha threshold of 0.05 (dark gray) and 1 × 10−4 (light gray).

SNP 1df interaction p value was observed for rs1260326 (for
G×Drinking habits on TG, P1df = 3.3e−6), a missense variant in
GCKR previously found associated with alcohol consumption [28, 29].
However, besides this particular signal, the distribution of interaction
effects at those variants did not indicate any clear trend (Fig. S7) and
the joint test of all single SNP [30] did not ﬁnd any signiﬁcant
enrichment for interaction effect among these variants (see
Supplementary Notes, Table S7). We also explored potential
enrichment for interaction at non-signiﬁcant SNPs. Such enrichment
would be of particular interest to increase power of G×E test through
2-step approaches [12, 31, 32] (see for example Fig. S8). The most
common 2-step approach consists of ﬁltering out SNPs displaying a
marginal genetic p value larger than a given α1 signiﬁcance
threshold. To assess the potential of this strategy in our data, we
quantiﬁed the enrichment of nominally signiﬁcant variants (i.e. P <
0.05) for G×E interaction effect while varying α1 between 0.1 and
10−6 applied to the aforementioned previous marginal GWAS
summary statistics. Some phenotype-exposure pairs show a slight
increase in the proportion of signiﬁcant G×E interactions, including in
particular TG and drinking habits (11% of the SNPs against the 5%
expected for α1 = 10−5). However, as illutrated in Fig. 3 which display
the enrichment along 0.05 and 1 × 10−4 conﬁdence interval, no
enrichment remains signiﬁcant after correction for multiple testing in
our data. We also considered using marginal genetic effect derived
from the stage 1 in CHARGE (Fig. S9). This analysis displayed a
modest enrichment for interaction with drinking exposure for lipids
and with current smoking for TG, with enrichment for some bins
falling outside the stringent conﬁdence interval (i.e., P < 1 × 10−4).
Small contribution of G×E at top variants but differences in
heritability stratiﬁed by exposure
We ﬁrst used VarExp, a tool we recently developed [22], to
estimate the variance explained by marginal genetic effects, the
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joint genetic and G×E interaction effects, and the interaction
effects only, at the top genome-wide signiﬁcant variants in each
locus for each phenotype-exposure-ancestry analysis (Table S8).
Marginal genetic effects explained between 0.09% and 8.72% of
the total phenotypic variance with an average of 3.59%. The
fraction of variance explained by the interaction effects only were
substantially smaller, varying between 0% and 0.41%, but were
statistically signiﬁcant for many analyses. The largest amount of
variance explained was observed for lipids traits, (average of
4.47% for the 2df, as compared to 0.81% for blood pressure
phenotypes). Looking at ancestry-speciﬁc results, we noted a
larger fraction of variance explained in the European ancestry
samples than in other ancestries, with greater differences
observed in lipids phenotypes and drinking exposures (7.11% of
explained variance in individuals from European ancestry versus
5.11% in other ancestries on average). We also noted a slightly
higher contribution of G×E in the African ancestry population
(0.15%) than in other ancestries (around 0.04%), in agreement
with the higher number of signiﬁcant interactions identiﬁed for
this ancestry.
Second, we estimated potential changes in the heritability of
the three lipids and two blood pressures (DBP and SBP) traits
across all individuals and in strata deﬁned by exposure, using the
LDSC approach [23] applied to summary statistics from the stage 1
analyses performed in the European ancestry population (Fig. 4,
Table S9). Because of potentially biased heritability estimates, we
performed a sensitivity analysis, re-deriving the heritability after
ﬁltering out SNPs based on their p value for heterogeneity in the
meta-analysis and selected the most reliable estimate (see Fig. S10
and Supplementary Notes). Based on those estimates, we
observed that heritability among exposed individuals was on
average smaller than among non-exposed individuals for current
smoking (h2 = 0.06 and h2 = 0.11, respectively) and for drinking
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Fig. 4 Heritability by exposure group. Heritability of the three lipids and two blood pressure phenotypes (DBP and SBP) derived using the
LDSC applied to summary statistics from the European ancestry samples meta-analysis. Heritability was derived for all individuals (All, yellow
bar) and for subset of unexposed (Une, teal bar) and exposed (Exp, purple bar) individuals. Error bars represent the 95% conﬁdence intervals.

habits (h2 = 0.12 and h2 = 0.15, respectively). Conversely, heritability was on average larger for current drinkers than non-current
drinkers (h2 = 0.15 and h2 = 0.11, respectively). However, only one
outcome-phenotype pair showed borderline nominal signiﬁcance
(HDL and drinking habits, with h2 = 0.19, P = 7.0 × 10−17, and h2 =
0.13, P = 3.1 × 10−10 for unexposed and exposed, respectively, P =
0.052), and this difference did not remain statistically signiﬁcant
after correction for multiple testing.
Differential pathways across exposures
To explore further differences in genetic effect between exposure
strata, we partitioned the genetic heritability estimated in
individuals from European ancestry across different functional
annotations [25, 26]. We ﬁrst considered baseline annotations
provided with the LDSC package and the GenoSkyline [33]
annotation set, a cell-type-speciﬁc annotation database derived
mainly from the Roadmap Epigenomics [34] (Figs. S11–15).
Because of the relatively modest sample size in some strata (N =
12,578 in the smallest strata, see Table S1), we focused on the
distribution of the estimated enrichment coefﬁcient between
exposed and unexposed. The majority of phenotype-exposure
pairs exhibited a similar enrichment pattern (Fig. S16). For
example, the enrichment estimates were signiﬁcantly correlated
for drinking habits exposure and lipids (correlations equal 0.76 (P =
9.5 × 10−24), 0.60 (P = 5.8 × 10−13) and 0.40 (P = 7.7 × 10−6) for

HDL, LDL and TG, respectively), suggesting that potential G×E
interactions for those phenotypes do not involve new pathways.
Conversely, LDL shows substantial variability in enrichment for the
three other exposures (correlations equal 0.10 (P = 0.25), 0.22 (P =
0.01), and 0.17 (P = 0.07), for current drinking, current smoking,
and ever smoking, respectively), suggesting those exposures might
activate new genetic pathways while reducing the effect of genetic
variants involved in unexposed individuals. We also noted
substantial variability for the phenotypes-exposure pairs showing
the largest differences in heritability (lipids and current smoking,
and BP and drinking habits, see Fig. 4). However, part of that
variability might be due to the reduced sample size in one of the
two strata, thus making interpretation challenging.
We next investigated whether exposures tended to display
systematic enrichment in speciﬁc tissues [26]. For each phenotype,
heritability was stratiﬁed based on annotation from 205 cell types
linked to 9 tissues (adipose, blood/immune, cardiovascular, central
nervous system, digestive, endocrine, liver, musculoskeletal/
connective, and other), in unexposed and exposed individuals
separately (Fig. 5, Figs. S17–S21). Because of unbalanced sample
size between strata, we focused on the relative differences in
median enrichment between exposed and unexposed by tissue,
and reported the proportion of cell types nominally signiﬁcant for
enrichment in each tissue. Overall, liver and adipose were the
most enriched and most signiﬁcant tissues for lipids traits, while
European Journal of Human Genetics (2022) 30:730 – 739
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Fig. 5 Stratiﬁcation of heritability by tissue. Cell-type partitioned heritability for each exposure was performed and further merged into nine
primary tissue categories. The top panels show the results for lipids: LDL (a), HDL (b), and TG (c), and the bottom panels show the results for
blood pressure: DBP (d), and SBP (e). For each phenotype-exposure pair we derived the difference in enrichment deﬁned as the median
enrichment in unexposed minus the median enrichment in exposed individuals (Δenrichment) per tissue. To highlight the signiﬁcance of
enrichment within each cell type, we scaled the size of each data point by the proportion of cell types that are nominally signiﬁcant (i.e., P <
0.05) after merging exposed and unexposed results.

showing variability between exposed and unexposed individuals.
LDL also showed some signiﬁcance and variability for cell types
mapped to digestive tissue for the drinking exposures and current
smoking (Fig. 5a). There was less signiﬁcant enrichment and a less
marked difference for BP traits, although we noticed a substantially larger enrichment in liver tissue among heavy drinkers versus
low-drinkers for DBP (Fig. 5d).

framework and result in a severe type I error rate inﬂation,
inducing false-positive associations (Fig. S22). However, main
genetic effects estimates are not biased in the 2df framework in
the case of a binary exposure (Fig. S23) but can be noisy in the
case of a continuous exposure (Fig. S24). These simulation studies
highlighted the special care required to interpret results from the
2df framework.

Genetic heterogeneity, power, and risk of bias for the test of
interaction in trans-ancestry analysis
Throughout this work, we used G×E interaction effect estimates
and p values derived using the standard 1df inverse-variance
meta-analysis scheme as described in Willer et al. [35], and applied
to the 1df interaction effect from each contributing cohort
similarly to the original GWIS papers. On the other hand, we
used the main genetic effect estimates and p values derived from
the 2df framework as described in Manning et al. [36]. Although,
the 2df framework provides a joint estimation of the main and
interaction effect coefﬁcients along with standard errors, we did
not use the interaction effect parameters from that model as we
identiﬁed potential biases in those estimates through several
simulation studies (see Supplementary notes for more details and
Table S10). Heterogeneity for both the main genetic effect and the
proportion of exposed individuals between the two cohorts (e.g.,
higher genetic effect in one cohort combined to a higher level of
exposure) can bias the interaction effect estimates in the 2df

DISCUSSION
In this study, we assembled and synthesized the results from 28
G×E interaction GWIS on lipid and blood pressure phenotypes
performed across four ancestries. Overall, we found the transancestry 2df test to be efﬁcient for SNP discovery, with the vast
majority of associations identiﬁed in ancestry-speciﬁc analyses
being conﬁrmed in the trans-ancestry analysis, while allowing for
a 10% increase in detection. However, our data also pointed
toward ancestry-speciﬁc patterns for interaction effects, especially for African ancestry populations. Differences were also
observed when comparing results across exposures. We noted a
greater increase in detection for lipid-associated variants when
accounting for interaction with drinking, and a greater increase
in detection for blood pressure-associated variants when
accounting for interaction with smoking. When leveraging
marginal genetic effect reported from previous studies to select
potential candidates for interaction effects, we did not observe
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any signiﬁcant enrichment for interaction effects whatever the
signiﬁcance level used. This is in agreement with our in-depth
comparison of main genetic and interaction effects using the
consortium data, which found only modest correlation between
the interaction and main effects coefﬁcients. Finally, our
assessment of variance explained by interaction effects suggests
that, even if small, accounting for interaction can help push
signals above the stringent genome-wide signiﬁcance threshold.
Furthermore, the stratiﬁcation of heritability by functional
annotations highlighted that exposures can induce divergent
mechanisms of phenotype production with modiﬁcation in the
associated genetic pathway and cell type involved.
Our estimation of the phenotypic variance explained by
marginal genetic effect and interaction shows, in agreement with
previous studies, that the contribution of G×E terms on top of
marginal genetic effect is relatively modest. It conﬁrms the likely
limited impact of discovering G×E for prediction purposes in the
general population [37]. The variability between non-smokers and
drinkers observed in the exposure-speciﬁc heritability is intriguing,
but might potentially be explained by other factors which cannot
be sorted out using these data. Further work is needed not only to
understand this heterogeneity but also to assess potential gain in
predictive power of polygenic risk score derived by exposure
strata [38]. Importantly, a modest contribution of G×E to
phenotypic variance does not rule out the potentially important
role of G×E in the etiology of these traits. And, for example, our
stratiﬁed heritability analyses suggest a potential change in the
genetic architecture of LDL conditional on smoking and BP traits
conditional on current drinking.
The statistical power of the GWIS varied substantially across
analyses. Taking the average sample size across all phenotypeexposure pairs analyzed per ancestry, there was 80% power at an
alpha threshold of 5 × 10−8 to detect interaction effect explaining
0.0096% (trans-ancestry, N = 440 K), 0.016% (EA, N = 271 K), 0.15%
(AA, N = 27 K), 0.034% (ASA, N = 123 K), and 0.22% (HISP, N = 19 K)
of the outcome variance. The observed enrichment for interaction
effects in AA as compared to other ancestries is therefore quite
striking, and further investigation in larger data is required. It would
also be of interest to explore whether interactions play a role in the
well documented differences in prevalence of both blood pressure
outcomes (e.g. hypertension [39]) and lipids (e.g. low HDL [40]) in
individuals from African-American ancestry. The sample size was
also critical when deriving heritability. Here, we only considered
the European ancestry data as sample size for other cohorts was
too small to derive meaningful estimates. Nevertheless, statistical
power remains limited in EA for LDSC stratiﬁed analyses based on
functional annotation, and future larger studies are also required to
validate the observed enrichments.
We fully appreciate that the results from the several experiments we conducted are challenging to aggregate into a single
uniform framework. Our analysis rather suggests ﬁrst that even
though related traits share some features; they can also display
substantial heterogeneity at other levels. For example, all lipids
harbor more signals when accounting for drinking exposures, but
at the same time display very different patterns when investigating functional enrichment. It also suggests that the links between
heritability, genetic mechanisms involved, and the resulting
distribution of G×E effect across SNPs are not straightforward.
Finally, our careful assessment of each step of the analyses
highlights that complexity also shows up at the methodological
level, with a potential for introducing bias at several stages, and so
the extra care needed for interpretation. Despite those limitations,
we argue that systematic and careful evaluation of G×E across
multiple phenotype-exposure-ancestry combinations, as done in
this study, still provides critical insight of the interplay between
genetic and environmental factors, offering long-term opportunities for numerous additional follow-up analyses down to the

biological mechanisms underlying the phenotypes and their
interaction with the environment.
DATA AVAILABILITY
All of the data used in this work are publicly available. Both the original GWAS
summary results and the re-processed statistics generated as part of this study are
available via dbGaP (accession number phs000930).

REFERENCES
1. McAllister K, Mechanic LE, Amos C, Aschard H, Blair IA, Chatterjee N, et al. Current
challenges and new opportunities for gene-environment interaction studies of
complex diseases. Am J Epidemiol. 2017;186:753–61.
2. Gauderman WJ, Mukherjee B, Aschard H, Hsu L, Lewinger JP, Patel CJ, et al.
Update on the state of the science for analytical methods for gene-environment
interactions. Am J Epidemiol. 2017;186:762–70.
3. Ritchie MD, Davis JR, Aschard H, Battle A, Conti D, Du M, et al. Incorporation of
biological knowledge into the study of gene-environment interactions. Am J
Epidemiol. 2017;186:771–7.
4. Aschard H. A perspective on interaction effects in genetic association studies.
Genet Epidemiol. 2016;40:678–88.
5. Rao DC, Sung YJ, Winkler TW, Schwander K, Borecki I, Cupples LA, et al. Multiancestry study of gene-lifestyle interactions for cardiovascular traits in 610 475
individuals from 124 cohorts: design and rationale. Circ Cardiovasc Genet.
2017;10:e001649.
6. Kraft P, Yen YC, Stram DO, Morrison J, Gauderman WJ. Exploiting gene-environment
interaction to detect genetic associations. Hum Hered. 2007;63:111–9.
7. Feitosa MF, Kraja AT, Chasman DI, Sung YJ, Winkler TW, Ntalla I, et al. Novel
genetic associations for blood pressure identiﬁed via gene-alcohol interaction in
up to 570K individuals across multiple ancestries. PLoS ONE. 2018;13:e0198166.
8. Sung YJ, Winkler TW, de Las Fuentes L, Bentley AR, Brown MR, Kraja AT, et al. A
large-scale multi-ancestry genome-wide study accounting for smoking behavior
identiﬁes multiple signiﬁcant loci for blood pressure. Am J Hum Genet.
2018;102:375–400.
9. Sung YJ, de Las Fuentes L, Winkler TW, Chasman DI, Bentley AR, Kraja AT, et al. A
multi-ancestry genome-wide study incorporating gene-smoking interactions
identiﬁes multiple new loci for pulse pressure and mean arterial pressure. Hum
Mol Genet. 2019;28:2615–33.
10. de Vries PS, Brown MR, Bentley AR, Sung YJ, Winkler TW, Ntalla I, et al. MultiAncestry Genome-Wide Association Study of Lipid Levels Incorporating GeneAlcohol Interactions. Am J Epidemiol. 2019;188:1033–54.
11. Bentley AR, Sung YJ, Brown MR, Winkler TW, Kraja AT, Ntalla I, et al. Multi-ancestry
genome-wide gene-smoking interaction study of 387,272 individuals identiﬁes
new loci associated with serum lipids. Nat Genet. 2019;51:636–48.
12. Kooperberg C, Leblanc M. Increasing the power of identifying gene x gene interactions in genome-wide association studies. Genet Epidemiol. 2008;32:255–63.
13. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation
PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.
14. Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al.
A global reference for human genetic variation. Nature. 2015;526:68–74.
15. Kato N, Loh M, Takeuchi F, Verweij N, Wang X, Zhang W, et al. Trans-ancestry
genome-wide association study identiﬁes 12 genetic loci inﬂuencing blood
pressure and implicates a role for DNA methylation. Nat Genet. 2015;47:1282–93.
16. Liang J, Le TH, Edwards DRV, Tayo BO, Gaulton KJ, Smith JA, et al. Single-trait and
multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations. PLoS Genet. 2017;13:e1006728.
17. Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B, et al. Genome-wide
association analysis identiﬁes novel blood pressure loci and offers biological
insights into cardiovascular risk. Nat Genet. 2017;49:403–15.
18. Below JE, Parra EJ, Gamazon ER, Torres J, Krithika S, Candille S, et al. Meta-analysis
of lipid-traits in Hispanics identiﬁes novel loci, population-speciﬁc effects, and
tissue-speciﬁc enrichment of eQTLs. Sci Rep. 2016;6:19429.
19. Prins BP, Kuchenbaecker KB, Bao Y, Smart M, Zabaneh D, Fatemifar G, et al.
Genome-wide analysis of health-related biomarkers in the UK Household Longitudinal Study reveals novel associations. Sci Rep. 2017;7:11008.
20. Surakka I, Horikoshi M, Magi R, Sarin AP, Mahajan A, Lagou V, et al. The impact of
low-frequency and rare variants on lipid levels. Nat Genet. 2015;47:589–97.
21. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M,
et al. Biological, clinical and population relevance of 95 loci for blood lipids.
Nature. 2010;466:707–13.
22. Laville V, Bentley AR, Prive F, Zhu X, Gauderman J, Winkler TW, et al. VarExp:
estimating variance explained by genome-wide G×E summary statistics. Bioinformatics. 2018;34:3412–4.

European Journal of Human Genetics (2022) 30:730 – 739

V. Laville et al.

739
23. Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J. Schizophrenia Working Group
of the Psychiatric Genomics C, et al. LD Score regression distinguishes confounding
from polygenicity in genome-wide association studies. Nat Genet. 2015;47:291–5.
24. Laville V, Majarian T, de Vries PS, Bentley AR, Feitosa MF, Sung YJ, et al. Deriving
stratiﬁed effects from joint models investigating Gene-Environment Interactions.
BMC Bioinformatics. 2020;21:251
25. Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, Loh PR, et al. Partitioning heritability by functional annotation using genome-wide association
summary statistics. Nat Genet. 2015;47:1228–35.
26. Finucane HK, Reshef YA, Anttila V, Slowikowski K, Gusev A, Byrnes A, et al. Heritability enrichment of speciﬁcally expressed genes identiﬁes disease-relevant
tissues and cell types. Nat Genet. 2018;50:621–9.
27. Klarin D, Damrauer SM, Cho K, Sun YV, Teslovich TM, Honerlaw J, et al. Genetics of
blood lipids among ~300,000 multi-ethnic participants of the Million Veteran
Program. Nat Genet. 2018;50:1514–23.
28. Clarke TK, Adams MJ, Davies G, Howard DM, Hall LS, Padmanabhan S, et al. Genomewide association study of alcohol consumption and genetic overlap with other
health-related traits in UK Biobank (N = 112 117). Mol Psychiatry. 2017;22:1376–84.
29. Jorgenson E, Thai KK, Hoffmann TJ, Sakoda LC, Kvale MN, Banda Y, et al. Genetic
contributors to variation in alcohol consumption vary by race/ethnicity in a large
multi-ethnic genome-wide association study. Mol Psychiatry. 2017;22:1359–67.
30. Aschard H, Tobin MD, Hancock DB, Skurnik D, Sood A, James A, et al. Evidence for
large-scale gene-by-smoking interaction effects on pulmonary function. Int J
Epidemiol. 2017;46:894–904.
31. Gauderman WJ, Zhang P, Morrison JL, Lewinger JP. Finding novel genes by
testing GxE interactions in a genome-wide association study. Genet Epidemiol.
2013;37:603–13.
32. Zhang P, Lewinger JP, Conti D, Morrison JL, Gauderman WJ. Detecting geneenvironment interactions for a quantitative trait in a genome-wide association
study. Genet Epidemiol. 2016;40:394–403.
33. Lu Q, Powles RL, Wang Q, He BJ, Zhao H. Integrative tissue-speciﬁc functional
annotations in the human genome provide novel insights on many complex
traits and improve signal prioritization in genome wide association studies. PLoS
Genet. 2016;12:e1005947.
34. Lu Q, Powles RL, Abdallah S, Ou D, Wang Q, Hu Y, et al. Systematic tissue-speciﬁc
functional annotation of the human genome highlights immune-related DNA
elements for late-onset Alzheimer’s disease. PLoS Genet. 2017;13:e1006933.
35. Willer CJ, Li Y, Abecasis GR. METAL: fast and efﬁcient meta-analysis of genomewide association scans. Bioinformatics 2010;26:2190–1.
36. Manning AK, LaValley M, Liu CT, Rice K, An P, Liu Y, et al. Meta-analysis of geneenvironment interaction: joint estimation of SNP and SNP x environment
regression coefﬁcients. Genet Epidemiol. 2011;35:11–8.
37. Aschard H, Chen J, Cornelis MC, Chibnik LB, Karlson EW, Kraft P. Inclusion of genegene and gene-environment interactions unlikely to dramatically improve risk
prediction for complex diseases. Am J Hum Genet. 2012;90:962–72.
38. Aschard H, Zaitlen N, Lindstrom S, Kraft P. Variation in predictive ability of
common genetic variants by established strata: the example of breast cancer and
age. Epidemiology. 2015;26:51–8.
39. Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015–2016. NCHS Data Brief.
2017 p. 1–8.
40. Carroll MD, Fryar CD, Nguyen DT. Total and high-density lipoprotein cholesterol
in adults: United States, 2015–2018. NCHS Data Brief, no 363. Hyattsville, MD:
National Center for Health Statistics. 2020.

ACKNOWLEDGEMENTS
We warmly thank all the past and present members of the Gene Lifestyle
Interaction Working Group. The various Gene-Lifestyle Interaction projects,
including this summary project, are largely supported by a grant from the U.S.
National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health,
R01HL118305. This work was also supported by the INCEPTION project (PIA/ANR-16CONV-0005). This research was supported in part by the Intramural Research
Program of the National Human Genome Research Institute, National Institutes of
Health. PSV was supported by American Heart Association grant number
18CDA34110116. YJS was supported by the K25HL121091 award from NHLBI. JG
was partly supported by the P01CA196569 grant from the National Institutes of
Health. Full set of study-speciﬁc funding sources and acknowledgments were
included in the separate publications [7–11].

COMPETING INTERESTS
The authors declare no competing interests.

ETHICAL APPROVAL
The study did not require ethical approval as no human subject was involved.

ADDITIONAL INFORMATION
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s41431-022-01045-6.
Correspondence and requests for materials should be addressed to Vincent Laville
or Hugues Aschard.
Reprints and permission information is available at http://www.nature.com/
reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional afﬁliations.

Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.

© The Author(s) 2022

THE CHARGE GENE-LIFESTYLE INTERACTIONS WORKING GROUP
Vincent Laville14, Timothy Majarian15, Yun J. Sung16, Karen Schwander16, Mary F. Feitosa17, Daniel I. Chasman18, Amy R. Bentley19,
Charles N. Rotimi19, L. Adrienne Cupples20,21, Paul S. de Vries22, Michael R. Brown22, Alanna C. Morrison22, Aldi T. Kraja17,
Mike Province17, C. Charles Gu16, W. James Gauderman23, D. C. Rao16, Alisa K. Manning15,24 and Hugues Aschard14,25
14
Department of Computational Biology, Institut Pasteur, Université de Paris, F-75015 Paris, France. 15Metabolism Program, Broad Institute of MIT and Harvard, Cambridge, MA
02142, USA. 16Division of Biostatistics, Washington University, St. Louis, MO 63110, USA. 17Division of Statistical Genomics, Department of Genetics, Washington University School
of Medicine, St. Louis, MO 63108-221, USA. 18Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02215, USA. 19Center for
Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. 20Department of Biostatistics,
Boston University School of Public Health, Boston, MA 2118, USA. 21Framingham Heart Study, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda,
MD 20982, USA. 22Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health
Science Center at Houston, Houston, TX 77030, USA. 23Division of Biostatistics, Department of Population and Public Health Sciences, University of Southern California, Los
Angeles, CA 90032, USA. 24Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA 02114, USA. 25Program in Genetic Epidemiology and
Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.

European Journal of Human Genetics (2022) 30:730 – 739

